Skip to main content
. 2018 Jan 31;8:71–81. doi: 10.1016/j.omto.2018.01.001

Figure 8.

Figure 8

Hyperactivation of PKR in Non-tumorigenic Human Cells Following Infection with D9- or D10-Deficient VACV

Human HCC (HepG2, Hep3B, and Huh7) or untransformed, non-tumorigenic cBAL111 human liver cells were either mock-infected or infected (MOI = 5) with WT VACV, D9-deficient VACV (ΔD9), or D10-deficient VACV (ΔD10). After 18.5 hr, total protein was isolated and analyzed by immunoblotting with either total PKR or a PKR phospho-specific antibody as described.36